Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Inventory (2020 - 2025)

Cytek Biosciences (CTKB) has disclosed Change in Inventory for 6 consecutive years, with -$2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory fell 2.55% year-over-year to -$2.1 million, compared with a TTM value of $5.2 million through Dec 2025, up 135.54%, and an annual FY2025 reading of $5.2 million, up 135.54% over the prior year.
  • Change in Inventory was -$2.1 million for Q4 2025 at Cytek Biosciences, down from $2.2 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $8.4 million in Q2 2022 and bottomed at -$6.3 million in Q4 2023.
  • Average Change in Inventory over 5 years is $546200.0, with a median of $1.2 million recorded in 2021.
  • The sharpest move saw Change in Inventory surged 3143.85% in 2022, then crashed 288.35% in 2024.
  • Year by year, Change in Inventory stood at $2.2 million in 2021, then tumbled by 184.48% to -$1.9 million in 2022, then tumbled by 236.15% to -$6.3 million in 2023, then soared by 68.42% to -$2.0 million in 2024, then dropped by 2.55% to -$2.1 million in 2025.
  • Business Quant data shows Change in Inventory for CTKB at -$2.1 million in Q4 2025, $2.2 million in Q3 2025, and $3.6 million in Q2 2025.